Table 2 Overview of prescribed inhaler devices used by 105 patients at the time of the survey
Inhaler device | Total number of patients, n (%) | Proportion within asthma patients, % | Proportion within COPD patients, % |
|---|---|---|---|
Breezhaler® | 18 (9.84) | 0.99 | 20.73 |
Diskus® | 9 (4.92) | 7.92 | 1.22 |
Pressurized metered-dose inhaler (pMDI) | 72 (39.34) | 46.53 | 30.49 |
Elpenhaler® | 1 (0.55) | 0 | 1.22 |
Forspiro® | 1 (0.55) | 0 | 1.22 |
Genuair® | 9 (4.92) | 3.96 | 6.10 |
Nexthaler® | 7 (3.83) | 4.95 | 2.44 |
Respimat® | 19 (10.38) | 10.89 | 9.76 |
Spiromax® | 3 (1.64) | 0.99 | 2.44 |
Turbohaler® | 31 (16.94) | 21.78 | 10.98 |
None of the above | 12 (6.56) | 1.98 | 12.20 |
No device was currently used | 1 (0.55) | 0 | 1.22 |